Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

1.

Antibody-functionalized peptidic membranes for neutralization of allogeneic skin antigen-presenting cells.

Wen Y, Liu W, Bagia C, Zhang S, Bai M, Janjic JM, Giannoukakis N, Gawalt ES, Meng WS.

Acta Biomater. 2014 Aug 10. pii: S1742-7061(14)00339-0. doi: 10.1016/j.actbio.2014.08.003. [Epub ahead of print]

PMID:
25117952
[PubMed - as supplied by publisher]
2.

Evaluation of ranirestat for the treatment of diabetic neuropathy.

Giannoukakis N.

Expert Opin Drug Metab Toxicol. 2014 Jul;10(7):1051-9. doi: 10.1517/17425255.2014.916277. Epub 2014 Apr 30.

PMID:
24785785
[PubMed - in process]
3.

Coassembly of amphiphilic peptide EAK16-II with histidinylated analogues and implications for functionalization of β-sheet fibrils in vivo.

Wen Y, Roudebush SL, Buckholtz GA, Goehring TR, Giannoukakis N, Gawalt ES, Meng WS.

Biomaterials. 2014 Jun;35(19):5196-205. doi: 10.1016/j.biomaterials.2014.03.009. Epub 2014 Mar 28.

PMID:
24680662
[PubMed - in process]
4.

Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD mice.

Di Caro V, Phillips B, Engman C, Harnaha J, Trucco M, Giannoukakis N.

PLoS One. 2014 Jan 17;9(1):e83575. doi: 10.1371/journal.pone.0083575. eCollection 2014.

PMID:
24465383
[PubMed - in process]
Free PMC Article
5.

It's time to bring dendritic cell therapy to type 1 diabetes.

Creusot RJ, Giannoukakis N, Trucco M, Clare-Salzler MJ, Fathman CG.

Diabetes. 2014 Jan;63(1):20-30. doi: 10.2337/db13-0886. Review. No abstract available.

PMID:
24357690
[PubMed - indexed for MEDLINE]
Free Article
6.

Immunoregulatory dendritic cells to treat autoimmunity are ready for the clinic. Interview by Katie Lockwood.

Giannoukakis N.

Immunotherapy. 2013 Sep;5(9):919-21. doi: 10.2217/imt.13.89.

PMID:
23998726
[PubMed - indexed for MEDLINE]
Free Article
7.

Retinoic acid-producing, ex-vivo-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B lymphocytes.

Di Caro V, Phillips B, Engman C, Harnaha J, Trucco M, Giannoukakis N.

Clin Exp Immunol. 2013 Nov;174(2):302-17. doi: 10.1111/cei.12177.

PMID:
23865694
[PubMed - indexed for MEDLINE]
8.

Tolerogenic dendritic cells for Type 1 diabetes.

Giannoukakis N.

Immunotherapy. 2013 Jun;5(6):569-71. doi: 10.2217/imt.13.50.

PMID:
23725280
[PubMed]
9.

Retaining antibodies in tumors with a self-assembling injectable system.

Wen Y, Kolonich HR, Kruszewski KM, Giannoukakis N, Gawalt ES, Meng WS.

Mol Pharm. 2013 Mar 4;10(3):1035-44. doi: 10.1021/mp300504z. Epub 2013 Feb 18.

PMID:
23419203
[PubMed - indexed for MEDLINE]
10.

Dendritic cell therapy for Type 1 diabetes suppression.

Giannoukakis N, Trucco M.

Immunotherapy. 2012 Oct;4(10):1063-74. doi: 10.2217/imt.12.76. Review.

PMID:
23148758
[PubMed - indexed for MEDLINE]
11.

A role for tolerogenic dendritic cell-induced B-regulatory cells in type 1 diabetes mellitus.

Giannoukakis N, Trucco M.

Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):279-87. doi: 10.1097/MED.0b013e328355461b. Review.

PMID:
22760513
[PubMed - indexed for MEDLINE]
12.

Sequence variation in promoter of Ica1 gene, which encodes protein implicated in type 1 diabetes, causes transcription factor autoimmune regulator (AIRE) to increase its binding and down-regulate expression.

Bonner SM, Pietropaolo SL, Fan Y, Chang Y, Sethupathy P, Morran MP, Beems M, Giannoukakis N, Trucco G, Palumbo MO, Solimena M, Pugliese A, Polychronakos C, Trucco M, Pietropaolo M.

J Biol Chem. 2012 May 18;287(21):17882-93. doi: 10.1074/jbc.M111.319020. Epub 2012 Mar 24.

PMID:
22447927
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetes.

Di Caro V, Giannoukakis N, Trucco M.

Rev Diabet Stud. 2012 Winter;9(4):348-56. doi: 10.1900/RDS.2012.9.348. Epub 2012 Dec 28. Review.

PMID:
23804272
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

FoxO6 integrates insulin signaling with gluconeogenesis in the liver.

Kim DH, Perdomo G, Zhang T, Slusher S, Lee S, Phillips BE, Fan Y, Giannoukakis N, Gramignoli R, Strom S, Ringquist S, Dong HH.

Diabetes. 2011 Nov;60(11):2763-74. doi: 10.2337/db11-0548. Epub 2011 Sep 22.

PMID:
21940782
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?

Phillips B, Trucco M, Giannoukakis N.

Clin Dev Immunol. 2011;2011:432016. doi: 10.1155/2011/432016. Epub 2011 Jul 18. Review.

PMID:
21785616
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients.

Giannoukakis N, Phillips B, Finegold D, Harnaha J, Trucco M.

Diabetes Care. 2011 Sep;34(9):2026-32. doi: 10.2337/dc11-0472. Epub 2011 Jun 16.

PMID:
21680720
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.

Di Caro V, D'Anneo A, Phillips B, Engman C, Harnaha J, Trucco M, Giannoukakis N.

Immunol Res. 2011 Aug;50(2-3):130-52. doi: 10.1007/s12026-011-8206-1.

PMID:
21476100
[PubMed - indexed for MEDLINE]
18.

Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.

Di Caro V, D'Anneo A, Phillips B, Engman C, Harnaha J, Lakomy R, Styche A, Trucco M, Giannoukakis N.

Clin Exp Immunol. 2011 Jul;165(1):60-76. doi: 10.1111/j.1365-2249.2011.04334.x. Epub 2011 Mar 17.

PMID:
21413939
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Drug delivery technologies for autoimmune disease.

Phillips BE, Giannoukakis N.

Expert Opin Drug Deliv. 2010 Nov;7(11):1279-89. doi: 10.1517/17425247.2010.527329. Epub 2010 Oct 20. Review.

PMID:
20958218
[PubMed - indexed for MEDLINE]
20.

A peptide-based material platform for displaying antibodies to engage T cells.

Zheng Y, Wen Y, George AM, Steinbach AM, Phillips BE, Giannoukakis N, Gawalt ES, Meng WS.

Biomaterials. 2011 Jan;32(1):249-57. doi: 10.1016/j.biomaterials.2010.08.083. Epub 2010 Sep 28.

PMID:
20880580
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk